DSI-pharm achieved GMP compliance for 400 MHz-NMR
Both, Bruker guidelines and the User Requirements Specification (URS) of DSI-pharm have been fulfilled to reach GMP compliance.
Using NMR as an analytical technique offers a rapid, convenient and cost effective method applicable to all steps of industrial processes (Table 2). Right from the beginning of the development phase through the test phase to the commercial production, all analytical methods in the pharmaceutical and biopharmaceutical industries must be carefully designed, appropriately validated and operated by trained and competent personnel. The dedicated NMR-Team of DSI-pharm knows how to help clients in analytical questions through every step of the pharmaceutical product development and in questions related to product controlling. DSI-pharm already proved its expertise e.g. in structure elucidation, purity determination (according to Ph. Eur. 2.2.33) or long term stability testing (Table 1).
Get in touch with our experts and benefit from this efficient technology!
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 65 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Tentamus Group
An der Industriebahn 5
13088 Berlin, Germany
www.tentamus.com
Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com
General Manager Pharma; DSI-pharm
Telefon: +49 441 3613265 449
E-Mail: serap.acikgoez@tentamus.com